• Americans are turning to peptides at an unprecedented rate without any clinical evidence that they are safe or effective.

  • Importing medicine from Canada's or other countries' drug supplies isn't safe or cost-effective.

  • More than a decade into the counterfeit pill crisis, fake prescription pills made with deadly ingredients are still killing Americans. 

  • Overwhelming demand for transformative GLP-1s has led to widespread illicit compounding and a boom in counterfeiting.

  • Several states are trying to to set price caps to reduce the cost of expensive medicine, but this could bankrupt pharmacies and threaten patient access.

July 6, 2026: Judge blocks Colorado price cap on Enbrel

July 7, 2026

The nations first upper payment limit, set to take effect in January 2027, has been temporarily paused. Chief Judge Daniel Domenico said Amgen would face significant and irreparable harm because of the price cap, and found that federal patent law likely preempted a state price cap, reported Reuters.

June 29, 2026: PSM releases road map to improve patient safety amidst compounding boom

June 30, 2026

A Call to Action: Restoring and Strengthening America’s Patient Safety System presents a two pillar system for regulators and lawmakers to preserve the FDAs gold standard.

Joint statement on warning to pharmacists about diverted HIV medicines being sold on online pharmacy-to-pharmacy platforms

June 30, 2026

ADAP Advocacy and the Partnership for Safe Medicines (PSM) issued the following joint statement as a warning to pharmacists that all discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces fit the definition of suspect product under U.S. Food and Drug Administration (FDA) guidelines and the Drug Supply Chain Security Act.

Pharmacists beware: Diverted HIV medicines are being sold on online pharmacy-to-pharmacy platforms

June 30, 2026

The Partnership for Safe Medicines and ADAP Advocacy are warning that discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces qualify as suspicious products under U.S. Food and Drug Administration guidelines and the Drug Supply Chain Security Act. Given the risks, we believe that it isn’t safe or cost-effective to purchase HIV products from these platforms.

Weight loss promotions are out of hand on social media, and it’s endangering patients

June 29, 2026

The internet is overrun with content promoting injectable weight loss medicines and there’s no way for viewers to know whether what they’re seeing is legitimate, genuine, safe, or true. Policymakers, social media platforms, and individuals can make changes to protect the public in this dangerous advertising environment.

PSM’s action plan to protect patients from unapproved compounded GLP-1s

June 25, 2026

Read our roadmap to uphold the gold standard system that protects Americans from untested and unsafe medicines.

June 22, 2026: Study links alternative funding programs to treatment delays

June 24, 2026

AFPs, which often force patients to source medicines overseas, may present access concerns according to a new study.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail
youtube-video-thumbnail

How can we secure patient safety in the compounded drug era?

youtube-video-thumbnail

What are research-grade drugs? They're not safe medicine.

Click the images below to see more recent videos.